Skip to content
← Full study record

NCT01083316 · MORE INFO

Limitations, agreements, and source contact

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis · Source last updated 2020-09-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
vaishali.sanchorawala@bmc.org
organization
Boston Medical Center
phone
6176386521
title
Vaishali Sanchorawala
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
vaishali.sanchorawala@bmc.org
organization
Boston Medical Center
phone
6176386521
title
Vaishali Sanchorawala

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice